comprehensive -WSS

comprehensive

author：knowledge 2025-08-25 07:30:03 - browse：2613

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Dogs on Prozac: What pet anti

explore

WSS

MassMutual is introducing free genetic testing for members

Key Senate committee drafts bipartisan bill to stem drug shortages

Cholera vaccine supply gets boost as demand surges globally

Medical bills so high, Medicare adding extra digits to claim forms

Dogs on Prozac: What pet anti

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Wikipedia

comprehensive

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Chinese researcher claims birth of first gene

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare Advantage insurers pressure Biden for bigger payments

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Q&A: Jennifer Adair on making gene therapy available globally

How one medical school became remarkably diverse

Erich Jarvis studies song birds to learn about human stuttering

FDA approval of Sarepta Duchenne genetic therapy gives me hope

MultiPlan and major insurers sued for alleged medical price

entertainment

H5N1 bird flu found in pasteurized milk: what we know

Close Medicare's dangerous gaps in addiction treatment coverage

Cell therapy fails to slow type 1 diabetes, but safety is established

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

With Wegovy coverage, Medicare patients may face high costs

Medical bills so high, Medicare adding extra digits to claim forms

hotspot

focus

explore

knowledge